• Markets

    Markets

    • Overview Indexes, movers, sectors and news
    • Indices World indexes, live
    • Sectors Breadth and rankings by sector
    • Heatmap The market sized by cap
    • Performers Top gainers and losers
    • Trending Most active right now
    • Earnings The earnings calendar
    • Dividends Upcoming ex-dividend dates
    • Crypto Coins and tokens, 24/7
    • Forex Currency pairs
    • Futures Index, energy and metal futures
    • Treasury Yields across the curve
    All markets
  • Research

    Research

    • Screener Filter stocks by any metric
    • Scanner Today's technical signals
    • Trend Score Rank trend strength
    • Insider trading Form 4 buys and sales
    • Compare Side-by-side symbols
    • Options Chains and watched options
    • Backtest Test an indicator rule
    • Strategy Build rule-based allocations
    • Chart settings Your chart templates
    All research
  • News

    News

    • News Headlines as they break
    • Discover Stories by topic
    All news
  • Learn
  • Paper trading
  • AI Chat
/
Watchlists Portfolios Alerts Sign in Get started
Menu

Markets

  • Overview
  • Indices
  • Sectors
  • Heatmap
  • Performers
  • Trending
  • Earnings
  • Dividends
  • Crypto
  • Forex
  • Futures
  • Treasury

Research

  • Screener
  • Scanner
  • Trend Score
  • Insider trading
  • Compare
  • Options
  • Backtest
  • Strategy
  • Chart settings

News

  • News
  • Discover
Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in
Advertisement
Advertisement
  1. Markets /
  2. News /
  3. Article

Market-Moving News for December 5th

Benzinga Newsdesk · Dec 5, 2025 ·11 months ago

MoversTrading Ideas

PRAX: 30% | Praxis Precision Medicines shares are trading higher after the company announced the completion of its pre-NDA meeting with the FDA and it gained alignment from the agency. The company announced results

PRAX: 30% | Praxis Precision Medicines shares are trading higher after the company announced the completion of its pre-NDA meeting with the FDA and it gained alignment from the agency. The company announced results from the registrational cohort of the EMBOLD study evaluating relutrigine for the treatment of patients with SCN2A and SCN8A developmental and epileptic encephalopathies.

 

NFE: 23% | New Fortress Energy shares are trading higher after the company announced it received Puerto Rico approval for a 7-year gas supply agreement.

 

VNDA: 17% | Vanda Pharmaceuticals shares are trading higher after the company announced that the FDA lifted its partial clinical hold on protocol VP-VLY-686-3403.

Read the original

Advertisement
Advertisement

Available on

Take Stock Master With You

Real-time quotes, AI insights, and portfolio tracking on the go.

Download on the App Store Get it on Google Play

Professional-grade financial analysis for stocks, options, and crypto. Powered by AI-driven insights and real-time market data.

Markets

  • Overview
  • Indices
  • Sectors
  • Heatmap
  • Performers
  • Trending
  • Earnings
  • Dividends

Assets

  • Crypto
  • Forex
  • Futures
  • Treasury
  • News
  • Discover

Research

  • Screener
  • Scanner
  • Trend Score
  • Insider trading
  • Compare
  • Options
  • Backtest
  • Strategy
  • Chart settings

Your Finabase

  • AI Chat
  • Watchlists
  • Portfolios
  • Alerts
  • Paper trading
  • Plans & pricing
  • Get the app

Learn

  • Finabase Learn
  • Investing basics
  • Technical indicators
  • Candlestick patterns

Company

  • Why Finabase
  • About us
  • Contact
  • Feedback
  • Privacy
  • Terms
  • Delete my data

Risk disclosure All investing involves risk, including the possible loss of principal. Past performance does not guarantee future results. Options and cryptocurrency trading involve substantial risk and are not appropriate for all investors. Market data is provided for informational purposes only and should not be construed as investment advice. Finabase is not a registered broker-dealer or investment advisor.

© 2026 Finabase. All rights reserved.